Neurocrine Biosciences, Inc. (NBIX) said that the U.S. Food and Drug Administration has approved CRENESSITY (crinecerfont) capsules ...
A 36-year-old man with a 6-month history of asthenia, impotence, loss of libido, polyuria, and polydipsia attended our department; he also reported needing to wake up twice at night to urinate and ...